Poster
Christoph Brey
Division of CLL, Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
Ulm, Baden-Wurttemberg, Germany
Mirela Dzindo
Division of CLL, Department of Internal Medicine III, University Hospital Ulm
Ulm, Baden-Wurttemberg, Germany
Deyan Y. Yosifov, PhD
Division of CLL, Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany
Ulm, Baden-Wurttemberg, Germany
Christof Schneider, MD
MD
Division of CLL, Department of Internal Medicine III, University Hospital Ulm
Ulm, Baden-Wurttemberg, Germany
Kirsten Fischer
Faculty of Medicine and University Hospital Cologne
Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital
Department I of Internal Medicine, Center for Integrated Oncology Aachen-Bonn-Cologne-Duesseldorf, University Hospital Cologne and University of Cologne
Cologne, Nordrhein-Westfalen, Germany
Petra Langerbeins, MD
Faculty of Medicine and University Hospital Cologne
Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne
Cologne, Germany
Barbara Eichhorst, MD
Associate Professor, Consultant Hematologist
Department I of Internal Medicine, University Hospital of Cologne
Cologne, Germany
Michael Hallek, MD, PhD
Principal Investigator, Director of Department I of Internal Medicine
German CLL Study Group, University Hospital of Cologne
Cologne, Germany
Hartmut Döhner
Department of Internal Medicine III, University Hospital Ulm
Ulm, Baden-Wurttemberg, Germany
Stephan Stilgenbauer, MD
Professor of Medicine, Medical Director
Division of CLL, Internal Medicine III, Ulm University
Ulm, Baden-Wurttemberg, Germany
Eugen Tausch, MD
Treating Physician and Research Fellow
Division of CLL, Department of Internal Medicine III, University Hospital Ulm
Ulm, Germany